NEO NeoGenomics, Inc. - Common Stock
$16.29
가격 · 8월 19, 2026
기준 재무 정보 7월 28, 2026
52주 범위
$6–$17
94% of range
애널리스트 평점
BUY
16 analysts
목표 주가
$20
+21% upside
P/E (TTM)
-68.7
ROE
-12.8%
순이익률
-14.8%
NeoGenomics, Inc. - Common Stock 정보 위키백과 회사 개요
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
더 보기
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.
## History
NeoGenomics first received state and national-level laboratory certifications in 2002. Three years later in 2005, the company developed a technical-only service model using FISH.
In 2013, the company launched its sequencing platform and was listed on the Nasdaq Stock Market as NEO. In 2014, NeoGenomics launched molecular tests including BTK and CALR mutation analysis.
In 2015, NeoGenomics acquired Clarient, Inc. and its subsidiary company, Clarient Diagnostic Services, Inc., a national cancer diagnostics laboratory with capabilities in immunohistochemistry for solid tumor cancers from GE Healthcare. Clarient is headquartered in Aliso Viejo, California; with an ancillary laboratory in Houston, Texas.
In November 2017, NeoGenomics established their first headquarters outside the United States in Rolle, Switzerland.
In September 2024, the District Court for the Middle District of North Carolina entered a permanent injunction against NeoGenomics’ accused RaDaR assay, which was preliminarily enjoined in December 2023.
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
NEO 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$16.29
시가총액
$2.11B
P/E (TTM)
-68.7
EPS (TTM)
—
매출 (TTM)
$727M
배당 수익률
—
ROE
-12.8%
부채/자본
0.4
52주 범위
$6 – $17
NEO 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
$727M
2016-12-31
→
2025-12-31
EPS
—
잉여현금흐름
$-22M
2017-12-31
→
2025-12-31
마진
-14.8%
2019-12-31
→
2025-12-31
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
NEO
동종업계 중앙값
P/E (TTM)
-68.7
32.1
P/S (TTM)
2.9
0.8
P/B
2.5
2.0
EV / EBITDA
-19.8
—
Price / FCF (주가 / FCF)
-97.0
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
NEO
동종업계 중앙값
Gross Margin (매출 총이익률)
43.2%
27.6%
Operating Margin (영업이익률)
-15.9%
—
Net Profit Margin (순이익률)
-14.8%
0.79%
ROA
-7.2%
1.3%
ROE
-12.8%
3.9%
ROIC
-9.6%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
NEO
동종업계 중앙값
Debt / Equity (부채 / 자기자본 비율)
0.4
—
Current Ratio (유동비율)
4.3
1.3
Quick Ratio (당좌 비율)
3.6
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
NEO
동종업계 중앙값
Revenue YoY (매출 YoY)
10.1%
—
Revenue CAGR 3Y (매출 CAGR 3년)
12.6%
—
Revenue CAGR 5Y (매출 CAGR 5년)
10.3%
—
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
NEO
동종업계 중앙값
NEO 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
16 명의 애널리스트
- 적극 매수 4 25.0%
- 매수 7 43.8%
- 보유 5 31.2%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
9 명의 애널리스트 · 2026-08-14
중앙값
$19.00
지금
$16.29
저가
$16.00
고가
$35.00
중앙값 목표
$19.00
+16.6%
평균 목표
$19.72
+21.1%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
0.01%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $0.05 | $0.03 | 0.02% |
| 2026년 3월 31일 | $0.01 | $0.01 | 0.00% |
| 2025년 12월 31일 | $0.06 | $0.04 | 0.02% |
| 2025년 9월 30일 | $0.03 | $0.02 | 0.01% |
| 2025년 6월 30일 | $0.03 | $0.02 | 0.01% |
| 2025년 3월 31일 | $0.00 | $-0.01 | 0.01% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| NEO | $1.51B | -49.0 | 10.1% | -14.8% | -12.8% | 43.2% |
| AVAH | $1.70B | 7.7 | 20.2% | 9.2% | 246.6% | 33.3% |
| GRDN | — | — | 17.9% | 3.4% | 24.8% | 20.2% |
| MD | $1.77B | 11.0 | -4.9% | 8.6% | 20.3% | — |
| ADUS | — | 20.6 | 23.2% | — | — | — |
| WGS | — | — | — | — | — | — |
| ASTH | $1.21B | 53.9 | 56.4% | 0.71% | 3.0% | — |
| AGL | $7.14B | — | -2.1% | -6.6% | -146.1% | — |
| OMDA | $922M | -45.1 | 53.2% | -4.9% | -5.8% | 65.7% |
| INNV | $500M | -16.8 | 11.8% | -3.5% | -12.0% | 18.0% |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 18
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $727M | $661M | $592M | $510M | $484M | $444M | $409M | $277M | $240M | $232M | $5M | $5M | |
| Cost of Revenue | $413M | $370M | $347M | $322M | $297M | $259M | $212M | $149M | $138M | $134M | $56M | $46M | |
| Gross Profit | $314M | $290M | $245M | $188M | $187M | $186M | $197M | $127M | $102M | $98M | $44M | $41M | |
| R&D Expense | $37M | $31M | $27M | $30M | $22M | $8M | $8M | $3M | $4M | $5M | $4M | $3M | |
| SG&A Expense | $273M | $260M | $243M | $243M | $221M | $144M | $128M | $85M | $70M | $64M | $34M | $24M | |
| Operating Expenses | $430M | $382M | $352M | $346M | $306M | $200M | $184M | $117M | $99M | $96M | $49M | $38M | |
| Operating Income | $-116M | $-92M | $-108M | $-158M | $-119M | $-14M | $13M | $10M | $3M | $2M | $-6M | $2M | |
| Interest Expense | · | · | $7M | $8M | $8M | $7M | $4M | $6M | $6M | · | $854.0K | $985.0K | |
| Interest Income | $9M | $18M | $17M | $6M | $3M | · | · | · | · | · | · | · | |
| Other Non-op | $296.0K | $-379.0K | $644.0K | $-213.0K | $-499.0K | $8M | $-5M | $14.0K | $-12.0K | $0 | $2M | $56.0K | |
| Pretax Income | $-110M | $-81M | $-97M | $-159M | $-15M | $-14M | $4M | $4M | $-3M | $-8M | $-4M | $1M | |
| Income Tax | $-2M | $-2M | $-9M | $-15M | $-7M | $-18M | $-4M | $1M | $-2M | $-2M | $-2M | $157.0K | |
| Net Income | $-108M | $-79M | $-88M | $-144M | $-8M | $4M | $8M | $3M | $-396.0K | $-6M | $-3M | $1M | |
| EPS (Basic) | · | · | · | · | · | · | · | · | · | · | $-0.04 | $0.02 | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | · | · | $-0.04 | $0.02 | |
| Shares (Basic) | 128,101,000 | 126,658,000 | 125,502,000 | 124,217,000 | 119,962,000 | 108,579,000 | 100,470,000 | 85,618,000 | 79,426,000 | 77,542,000 | 60,526,000 | 53,483,000 | |
| Shares (Diluted) | 128,101,000 | 126,658,000 | 125,502,000 | 124,217,000 | 119,962,000 | 111,794,000 | 103,615,000 | 91,568,000 | 79,426,000 | 77,542,000 | 60,526,000 | 56,016,000 | |
| EBITDA | $-116M | $-92M | $-108M | $-158M | $-119M | $-14M | $13M | · | $2M | · | $-6M | · |
대차대조표 29
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $160M | $367M | $342M | $263M | $317M | $229M | $173M | $10M | $13M | $13M | $23M | $34M | |
| Receivables | $159M | $151M | $131M | $120M | $112M | $107M | $94M | $77M | $60M | $56M | $49M | $20M | |
| Inventory | $29M | $27M | $24M | $24M | $23M | $30M | $14M | $9M | $7M | $6M | $5M | $3M | |
| Prepaid Expense | $21M | $20M | $18M | $15M | $12M | $12M | $6M | $8M | $5M | $5M | $5M | $1M | |
| Other Current Assets | $7M | $12M | $8M | $8M | $8M | $5M | $3M | $561.0K | $1M | · | · | · | |
| Current Assets | $376M | $596M | $597M | $605M | $682M | $449M | $291M | $104M | $86M | $79M | $82M | $59M | |
| PP&E (Net) | $85M | $94M | $92M | $102M | $109M | $86M | $64M | $61M | $37M | $34M | $35M | $15M | |
| PP&E (Gross) | $294M | $284M | $250M | $234M | $219M | $179M | $133M | $111M | $77M | $61M | $61M | $35M | |
| Accum. Depreciation | $209M | $190M | $158M | $132M | $110M | $93M | $69M | $50M | $41M | $27M | $27M | $20M | |
| Goodwill | $524M | $523M | $523M | $523M | $527M | $211M | $199M | $198M | $147M | $147M | $147M | $3M | |
| Intangibles | $287M | $340M | $373M | $408M | $442M | $121M | $127M | $140M | $74M | $77M | $88M | $4M | |
| Other Non-current Assets | $9M | $6M | $5M | $5M | $7M | $5M | $3M | $3M | $891.0K | $174.0K | $129.0K | $141.0K | |
| Total Assets | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B | $988M | $710M | $505M | $344M | $337M | $351M | $81M | |
| Accounts Payable | $23M | $22M | $20M | $21M | $18M | $25M | $20M | $18M | $10M | $17M | $12M | $6M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Liabilities | $88M | $301M | $96M | $90M | $87M | $73M | $64M | $61M | $36M | $38M | $40M | $15M | |
| Capital Leases | $63M | $61M | $68M | $69M | $72M | $42M | $24M | $5M | $5M | $5M | $5M | $5M | |
| Deferred Tax | $18M | $22M | $24M | $35M | $55M | $5M | $16M | $22M | $7M | · | $16M | $821.0K | |
| Other Non-current Liabilities | $12M | $12M | $13M | $13M | $14M | $4M | $4M | $3M | $283.0K | · | · | · | |
| Total Liabilities | $523M | $736M | $740M | $742M | $762M | $294M | $202M | $185M | $140M | $151M | $113M | $21M | |
| Long-term Debt | $342M | $541M | $538M | · | · | · | · | $102M | $97M | $98M | $55M | · | |
| Total Debt | $342M | $541M | · | · | · | $0 | · | · | $95M | · | $53M | · | |
| Common Stock | · | · | · | · | · | · | · | · | · | · | · | $60.0K | |
| Retained Earnings | $-434M | $-326M | $-247M | $-159M | $-15M | $-7M | $-11M | $-19M | $-58M | $-52M | $-22M | $-19M | |
| Treasury Stock | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $4.0K | $-206.0K | $-2M | $-4M | $-638.0K | $10.0K | $-2M | $-579.0K | $274.0K | · | · | · | |
| Stockholders' Equity | $837M | $902M | $942M | $998M | $1.11B | $694M | $507M | $320M | $172M | $162M | $209M | $60M | |
| Liabilities + Equity | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B | $988M | $710M | $505M | $344M | $337M | $351M | $81M | |
| Shares Outstanding | 128,989,152 | 128,145,333 | 127,369,142 | 126,913,992 | 124,107,500 | 112,075,474 | 104,781,236 | 94,465,440 | 80,462,574 | 78,571,158 | 75,820,307 | 60,242,818 |
현금 흐름 15
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $26M | $20M | $16M | $16M | $16M | $7M | $5M | |
| Stock-based Comp | $41M | $33M | $25M | $25M | $22M | $10M | $10M | $7M | $6M | $5M | $3M | $641.0K | |
| Deferred Tax | $-3M | $-3M | $-10M | $-15M | $-7M | $-18M | $-4M | $2M | $-2M | $-2M | $-2M | · | |
| Amort. of Intangibles | $32M | $33M | $35M | $34M | $23M | $10M | $10M | $6M | $7M | $7M | $412.0K | $295.0K | |
| Restructuring | $0 | $7M | $11M | $5M | $0 | $0 | · | · | · | · | · | · | |
| Operating Cash Flow | $5M | $7M | $-2M | $-66M | $-27M | $1M | $23M | $45M | $18M | $21M | $6M | $9M | |
| CapEx | $27M | $41M | $29M | $31M | $64M | $29M | $20M | $14M | $14M | $8M | $2M | $4M | |
| Investing Cash Flow | $-12M | $13M | $77M | $517.0K | $-632M | $-159M | $-20M | $-140M | $-14M | · | · | · | |
| Stock Issued | $962.0K | $5M | $5M | $13M | $15M | $20M | $11M | $9M | $3M | · | · | $34M | |
| Net Stock Activity | $962.0K | $5M | $5M | $13M | $15M | $20M | $11M | · | · | · | · | · | |
| Financing Cash Flow | $-200M | $5M | $5M | $12M | $725M | $236M | $159M | $92M | $-4M | · | · | · | |
| Net Change in Cash | · | · | · | · | · | $78M | $163M | $-3M | $296.0K | $-11M | $-10M | $29M | |
| Taxes Paid | $515.0K | $207.0K | $175.0K | $180.0K | $148.0K | $246.0K | $319.0K | $-31.0K | $284.0K | $290.0K | · | · | |
| Free Cash Flow | $-22M | $-34M | $-31M | $-97M | $-91M | $-28M | $3M | · | $4M | · | $4M | · | |
| Levered FCF | · | · | $-37M | $-98M | $-94M | $-26M | $-5M | · | · | · | $4M | · |
수익성 8
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.2% | 43.9% | 41.3% | 36.9% | 38.6% | 41.8% | 48.1% | · | · | · | 875.1% | · | |
| Operating Margin | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | · | · | · | -112.7% | · | |
| Net Margin | -14.8% | -11.9% | -14.9% | -28.3% | -1.7% | 0.94% | 2.0% | · | · | · | -50.7% | · | |
| Pretax Margin | -15.2% | -12.2% | -16.4% | -31.3% | -3.1% | -3.2% | 0.89% | · | · | · | -89.8% | · | |
| EBITDA Margin | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | · | · | · | -112.7% | · | |
| ROA | -7.2% | -4.7% | -5.1% | -8.0% | -0.58% | 0.49% | 1.3% | · | -0.25% | · | -1.1% | · | |
| ROE | -12.8% | -8.7% | -9.3% | -14.3% | -0.74% | 0.61% | 1.6% | · | -0.50% | · | -1.9% | · | |
| ROIC | -9.6% | -6.2% | -10.4% | -14.3% | -5.9% | 0.60% | 5.6% | · | 0.21% | · | -1.2% | · |
유동성 및 지급능력 5
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 2.0 | 6.2 | 6.7 | 7.8 | 6.1 | 4.5 | · | 2.4 | · | 2.5 | · | |
| Quick Ratio | 3.6 | 1.7 | 4.9 | 4.3 | 4.9 | 4.6 | 4.2 | · | 2.1 | · | 1.8 | · | |
| Debt / Equity | 0.4 | 0.6 | · | · | · | 0.0 | · | · | 0.5 | · | 0.3 | · | |
| LT Debt / Equity | 0.4 | 0.4 | · | · | · | · | · | · | 0.5 | · | 0.2 | · | |
| Interest Coverage | · | · | -15.6 | -104.7 | -23.4 | -2.0 | 3.5 | · | · | · | -6.6 | · |
효율성 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.3 | 0.3 | 0.3 | 0.5 | 0.7 | · | · | · | 0.0 | · | |
| Inventory Turnover | 14.9 | 14.6 | 14.3 | 13.5 | 11.2 | 11.8 | 18.4 | · | 20.1 | · | 14.5 | · | |
| Receivables Turnover | 4.7 | 4.7 | 4.7 | 4.4 | 4.4 | 4.4 | 4.8 | · | · | · | 0.1 | · |
성장률 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 11.7% | 16.1% | 5.2% | 9.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.6% | 10.9% | 10.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 14
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $727M | $661M | $592M | $510M | $484M | $444M | $409M | $277M | $240M | $232M | $5M | $5M | |
| Net Income TTM | $-108M | $-79M | $-88M | $-144M | $-8M | $4M | $8M | $3M | $-396.0K | $-6M | $-3M | $1M | |
| Market Cap | $1.51B | $2.10B | $2.05B | $1.15B | $3.82B | $5.64B | $2.76B | · | $713M | · | $597M | · | |
| Enterprise Value | $1.69B | $2.27B | · | · | · | $5.41B | · | · | $795M | · | $626M | · | |
| P/E | -49.0 | -68.7 | -67.4 | -38.5 | -142.2 | -224.3 | -121.9 | -52.5 | -36.9 | -35.7 | -196.8 | 208.5 | |
| P/S | 2.1 | 3.2 | 3.5 | 2.2 | 7.9 | 12.7 | 6.8 | · | 3.0 | · | 119.3 | · | |
| P/B | 1.8 | 2.3 | 2.2 | 1.1 | 3.5 | 8.1 | 5.4 | · | 4.1 | · | 2.8 | · | |
| P / Tangible Book | 58.7 | 52.6 | 45.0 | 17.1 | 27.5 | 15.6 | · | · | · | · | · | · | |
| P / Cash Flow | 288.1 | 298.9 | -1051.4 | -17.4 | -143.1 | 3864.0 | 118.2 | · | 39.5 | · | 93.3 | · | |
| P / FCF | -69.2 | -61.7 | -66.9 | -11.8 | -42.1 | -204.1 | 827.3 | · | 164.0 | · | 142.8 | · | |
| EV / EBITDA | -14.6 | -24.7 | · | · | · | -386.8 | · | · | 342.1 | · | -111.1 | · | |
| EV / FCF | -77.6 | -66.8 | · | · | · | -195.9 | · | · | 182.9 | · | 149.9 | · | |
| EV / Revenue | 2.3 | 3.4 | · | · | · | 12.2 | · | · | 3.3 | · | 125.2 | · | |
| Earnings Yield | -2.0% | -1.5% | -1.5% | -2.6% | -0.70% | -0.45% | -0.82% | -1.9% | -2.7% | -2.8% | -0.51% | 0.48% |
손익계산서 16
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $202M | $187M | $190M | $188M | $181M | $168M | $172M | $168M | $165M | $156M | $156M | $152M | $147M | $137M | $139M | $129M | |
| Cost of Revenue | $110M | $106M | $107M | $107M | $104M | $95M | $95M | $93M | $92M | $91M | $88M | $90M | $87M | $82M | $82M | $80M | |
| Gross Profit | $92M | $81M | $83M | $80M | $77M | $73M | $77M | $75M | $72M | $65M | $68M | $62M | $60M | $55M | $57M | $49M | |
| R&D Expense | $11M | $10M | $9M | $9M | $9M | $10M | $8M | $8M | $8M | $8M | $7M | $5M | $8M | $7M | $7M | $7M | |
| SG&A Expense | $64M | $66M | $64M | $70M | $72M | $68M | $64M | $67M | $63M | $66M | $60M | $61M | $60M | $62M | $55M | $64M | |
| Operating Expenses | $102M | $99M | $97M | $107M | $125M | $101M | $96M | $96M | $94M | $96M | $86M | $87M | $90M | $90M | $83M | $88M | |
| Operating Income | $-10M | $-18M | $-13M | $-27M | $-48M | $-28M | $-18M | $-21M | $-22M | $-31M | $-19M | $-24M | $-30M | $-35M | $-26M | $-40M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $2M | · | $-3M | $-3M | $2M | · | $139.0K | |
| Interest Income | $1M | $1M | $2M | $2M | $2M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $4M | $3M | · | · | |
| Other Non-op | $-17.0K | $-12.0K | $84.0K | $-335.0K | $482.0K | $65.0K | $-431.0K | $317.0K | $-2.0K | $-263.0K | $124.0K | $-96.0K | $730.0K | $-114.0K | $-1.0K | $25.0K | |
| Pretax Income | $2M | $-18M | $-12M | $-26M | $-46M | $-26M | $-16M | $-18M | $-19M | $-28M | $-15M | $-21M | $-27M | $-34M | $-26M | $-40M | |
| Income Tax | $-412.0K | $-472.0K | $-3M | $740.0K | $-724.0K | $266.0K | $-804.0K | $-150.0K | $-375.0K | $-620.0K | $-960.0K | $-3M | $-2M | $-3M | $-3M | $-3M | |
| Net Income | $2M | $-17M | $-10M | $-27M | $-45M | $-26M | $-15M | $-18M | $-19M | $-27M | $-14M | $-19M | $-24M | $-31M | $-23M | $-37M | |
| Shares (Basic) | 129,628,000 | 129,166,000 | -255,639,000 | 128,415,000 | 127,949,000 | 127,376,000 | -252,811,000 | 126,953,000 | 126,405,000 | 126,111,000 | -250,567,000 | 125,687,000 | 125,356,000 | 125,026,000 | -247,906,000 | 124,425,000 | |
| Shares (Diluted) | 130,831,000 | 129,166,000 | -255,639,000 | 128,415,000 | 127,949,000 | 127,376,000 | -252,811,000 | 126,953,000 | 126,405,000 | 126,111,000 | -250,567,000 | 125,687,000 | 125,356,000 | 125,026,000 | -247,906,000 | 124,425,000 | |
| EBITDA | $-10M | $-18M | · | $-27M | $-48M | $-28M | · | $-21M | $-22M | $-31M | · | $-24M | $-30M | $-35M | · | $-40M |
대차대조표 27
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $146M | $146M | $160M | $164M | $155M | $346M | $367M | $362M | $355M | $332M | · | $306M | $289M | $276M | · | $266M | |
| Receivables | $175M | $167M | $159M | $155M | $153M | $151M | $151M | $151M | $147M | $140M | · | $133M | $125M | $119M | · | $112M | |
| Inventory | $27M | $30M | $29M | $28M | $34M | $30M | $27M | $24M | $23M | $20M | · | $24M | $25M | $24M | · | $24M | |
| Prepaid Expense | $24M | $24M | $21M | $22M | $23M | $23M | $20M | $18M | $17M | $19M | · | $19M | $17M | $16M | · | $17M | |
| Other Current Assets | $10M | $7M | $7M | $11M | $10M | $12M | $12M | $8M | $9M | $9M | · | $9M | $8M | $8M | · | $8M | |
| Current Assets | $381M | $374M | $376M | $382M | $393M | $574M | $596M | $590M | $584M | $574M | · | $587M | $585M | $585M | · | $603M | |
| PP&E (Net) | $81M | $84M | $85M | $85M | $85M | $90M | $94M | $93M | $92M | $88M | · | $95M | $100M | $103M | · | $107M | |
| PP&E (Gross) | · | · | $294M | · | · | · | $284M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $223M | $216M | $209M | $209M | $201M | $199M | $190M | $181M | $176M | $168M | · | $155M | $147M | $139M | · | $125M | |
| Goodwill | $524M | $524M | $524M | $524M | $524M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | · | $523M | |
| Intangibles | $271M | $279M | $287M | $294M | $302M | $331M | $340M | $348M | $356M | $365M | · | $382M | $391M | $399M | · | $417M | |
| Other Non-current Assets | $9M | $10M | $9M | $8M | $7M | $6M | $6M | $6M | $4M | $4M | · | $5M | $5M | $5M | · | $7M | |
| Total Assets | $1.35B | $1.35B | $1.36B | $1.37B | $1.39B | $1.60B | $1.64B | $1.64B | $1.64B | $1.64B | · | $1.68B | $1.70B | $1.71B | · | $1.76B | |
| Accounts Payable | $21M | $26M | $23M | $23M | $27M | $16M | $22M | $17M | $17M | $18M | · | $17M | $18M | $23M | · | $14M | |
| Current Liabilities | $106M | $85M | $88M | $98M | $100M | $280M | $301M | $296M | $290M | $77M | · | $93M | $95M | $87M | · | $85M | |
| Capital Leases | $65M | $61M | $63M | $64M | $67M | $60M | $61M | $62M | $63M | $65M | · | $62M | $65M | $67M | · | $70M | |
| Deferred Tax | $17M | $17M | $18M | $21M | $20M | $21M | $22M | $23M | $23M | $23M | · | $25M | $29M | $32M | · | $38M | |
| Other Non-current Liabilities | $862.0K | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $13M | · | $13M | $13M | $13M | · | $14M | |
| Total Liabilities | $567M | $518M | $523M | $536M | $540M | $713M | $736M | $733M | $727M | $717M | · | $731M | $739M | $735M | · | $743M | |
| Long-term Debt | · | · | $342M | · | · | · | $541M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $374M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-449M | $-451M | $-434M | $-424M | $-397M | $-352M | $-326M | $-310M | $-293M | $-274M | · | $-233M | $-214M | $-190M | · | $-136M | |
| Treasury Stock | $25M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $4.0K | $4.0K | $4.0K | $71.0K | $29.0K | $-56.0K | $-206.0K | $-643.0K | $-1M | $-1M | · | $-2M | $-3M | $-3M | · | $-5M | |
| Stockholders' Equity | $786M | $829M | $837M | $838M | $854M | $888M | $902M | $908M | $916M | $923M | $942M | $947M | $956M | $974M | $998M | $1.01B | |
| Liabilities + Equity | $1.35B | $1.35B | $1.36B | $1.37B | $1.39B | $1.60B | $1.64B | $1.64B | $1.64B | $1.64B | · | $1.68B | $1.70B | $1.71B | · | $1.76B | |
| Shares Outstanding | 127,917,946 | 129,653,642 | 128,145,333 | 128,885,101 | 128,681,713 | 128,356,327 | 128,145,333 | 128,061,944 | 127,851,113 | 127,434,786 | 127,369,142 | 127,261,476 | 127,144,418 | 127,200,491 | 126,913,992 | 126,562,037 |
현금 흐름 13
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $8M | $10M | $8M | $10M | $12M | $11M | $8M | $0 | $9M | $8M | $7M | $0 | $6M | $5M | $5M | $4M | |
| Amort. of Intangibles | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $9M | $9M | $9M | $9M | $9M | $8M | |
| Restructuring | · | · | · | · | · | · | · | · | · | $2M | $1M | $2M | $3M | $5M | · | $0 | |
| Operating Cash Flow | $20M | $-8M | $1M | $9M | $20M | $-25M | $10M | $9M | $14M | $-26M | $18M | $-5M | $-2M | $-13M | $-4M | $-16M | |
| CapEx | $8M | $5M | $8M | $8M | $6M | $4M | $12M | $11M | $13M | $6M | $7M | $4M | $7M | $10M | $5M | $8M | |
| Investing Cash Flow | $-8M | $-5M | $-6M | $-277.0K | $-9M | $4M | $-5M | $-4M | $7M | $15M | $17M | $21M | $15M | $24M | $-1M | $-4M | |
| Stock Issued | $2M | $-338.0K | $431.0K | $765.0K | $-1M | $949.0K | $687.0K | $1M | $2M | $816.0K | $1M | $2M | $93.0K | $1M | $2M | $3M | |
| Net Stock Activity | · | $-338.0K | · | · | · | $949.0K | · | · | · | $816.0K | · | · | · | $1M | · | · | |
| Financing Cash Flow | $-12M | $-338.0K | $431.0K | $765.0K | $-202M | $949.0K | $687.0K | $1M | $2M | $816.0K | $1M | $2M | $64.0K | $1M | $2M | $3M | |
| Net Change in Cash | · | · | · | $9M | · | · | · | $7M | $23M | $-11M | · | $17M | $13M | $12M | · | $-18M | |
| Taxes Paid | $711.0K | $0 | $57.0K | $0 | $458.0K | $0 | $-112.0K | $143.0K | $87.0K | $89.0K | $0 | $0 | $175.0K | $0 | $25.0K | $26.0K | |
| Free Cash Flow | · | $-13M | · | · | · | $-30M | · | · | · | $-32M | · | · | · | $-23M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-33M | · | · | · | · | · | · |
수익성 8
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.6% | 43.3% | · | 42.8% | 42.6% | 43.6% | · | 44.6% | 44.1% | 41.9% | · | 41.0% | 40.8% | 40.0% | · | 38.0% | |
| Operating Margin | -4.9% | -9.8% | · | -14.4% | -26.3% | -16.6% | · | -12.6% | -13.3% | -19.6% | · | -15.9% | -20.3% | -25.6% | · | -30.7% | |
| Net Margin | 1.1% | -9.2% | · | -14.4% | -24.9% | -15.4% | · | -10.5% | -11.3% | -17.3% | · | -12.2% | -16.6% | -22.4% | · | -28.6% | |
| Pretax Margin | 0.91% | -9.4% | · | -14.1% | -25.3% | -15.3% | · | -10.6% | -11.6% | -17.7% | · | -14.1% | -18.1% | -24.6% | · | -30.8% | |
| EBITDA Margin | -4.9% | -9.8% | · | -14.4% | -26.3% | -16.6% | · | -12.6% | -13.3% | -19.6% | · | -15.9% | -20.3% | -25.6% | · | -30.7% | |
| ROA | 0.16% | -1.2% | · | -1.8% | -3.0% | -1.6% | · | -1.1% | -1.1% | -1.6% | · | -1.1% | -1.4% | -1.7% | · | -2.0% | |
| ROE | 0.27% | -2.0% | · | -3.1% | -5.1% | -2.9% | · | -1.9% | -2.0% | -2.9% | · | -1.9% | -2.4% | -3.0% | · | -3.4% | |
| ROIC | -1.0% | -2.1% | · | -3.3% | -5.5% | -3.2% | · | -2.3% | -2.4% | -3.2% | · | -2.2% | -2.9% | -3.3% | · | -3.6% |
유동성 및 지급능력 5
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 4.4 | · | 3.9 | 3.9 | 2.1 | · | 2.0 | 2.0 | 7.5 | · | 6.3 | 6.2 | 6.8 | · | 7.1 | |
| Quick Ratio | 3.0 | 3.7 | · | 3.3 | 3.1 | 1.8 | · | 1.7 | 1.7 | 6.2 | · | 4.7 | 4.4 | 4.6 | · | 4.4 | |
| Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -18.1 | · | 8.5 | 11.8 | · | · | -284.2 |
효율성 3
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 3.6 | 3.6 | · | 4.1 | 3.6 | 3.8 | · | 3.8 | 3.8 | 4.1 | · | 3.7 | 3.7 | 3.4 | · | 3.5 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 |
가치 평가 (TTM) 13
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $757M | $724M | · | $705M | $682M | $657M | · | $641M | $620M | $592M | · | $565M | $538M | $508M | · | $492M | |
| Net Income TTM | $-87M | $-115M | · | $-116M | $-107M | $-89M | · | $-82M | $-89M | $-101M | · | $-110M | $-127M | $-152M | · | $-142M | |
| Market Cap | $1.87B | $962M | · | $995M | $941M | $1.22B | · | $1.89B | $1.77B | $2.00B | · | $1.57B | $2.04B | $2.21B | · | $1.09B | |
| Enterprise Value | $2.10B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -60.8 | -30.9 | · | -32.2 | -30.5 | -39.5 | · | -61.5 | -57.8 | -65.5 | · | -51.2 | -67.0 | -72.5 | · | -35.9 | |
| P/S | 2.5 | 1.3 | · | 1.4 | 1.4 | 1.9 | · | 2.9 | 2.9 | 3.4 | · | 2.8 | 3.8 | 4.4 | · | 2.2 | |
| P/B | 2.4 | 1.2 | · | 1.2 | 1.1 | 1.4 | · | 2.1 | 1.9 | 2.2 | · | 1.7 | 2.1 | 2.3 | · | 1.1 | |
| P / Tangible Book | · | 37.2 | · | 50.3 | 33.5 | 35.6 | · | 50.5 | 48.3 | 55.8 | · | 36.6 | 47.8 | 42.4 | · | 14.9 | |
| P / Cash Flow | · | -118.2 | · | · | · | -48.1 | · | · | · | -77.3 | · | · | · | -174.5 | · | · | |
| P / FCF | · | -73.2 | · | · | · | -40.8 | · | · | · | -63.6 | · | · | · | -97.9 | · | · | |
| EV / EBITDA | -214.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 2.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -1.6% | -3.2% | · | -3.1% | -3.3% | -2.5% | · | -1.6% | -1.7% | -1.5% | · | -1.9% | -1.5% | -1.4% | · | -2.8% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 매출 | $727M | $661M | $592M | $510M | $484M |
| 매출 총이익률 % | 43.2% | 43.9% | 41.3% | 36.9% | 38.6% |
| 영업이익률 % | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% |
| 순이익 | $-108M | $-79M | $-88M | $-144M | $-8M |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | 0.4 | 0.6 | — | — | — |
| 유동비율 | 4.3 | 2.0 | 6.2 | 6.7 | 7.8 |
| 당좌 비율 | 3.6 | 1.7 | 4.9 | 4.3 | 4.9 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-22M | $-34M | $-31M | $-97M | $-91M |
최신 뉴스 이 회사 관련 최근 헤드라인
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 299개의 제출자 · $1.8B 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 64 (+22 이전 분기 대비) | 38 (+1 이전 분기 대비) | 93 (+20 이전 분기 대비) | 59 (-26 이전 분기 대비) | +33.5M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| First Light Asset Management, LLC | $179,158,241 | 12,279,523 | 9.76% | 주식 |
| VANGUARD GROUP INC | $150,953,759 | 12,836,204 | 8.22% | 주식 |
| FIRST TRUST ADVISORS LP | $147,552,477 | 10,113,261 | 8.04% | 주식 |
| Greenhouse Funds LLLP | $125,097,724 | 8,574,210 | 6.82% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $117,615,272 | 8,061,362 | 6.41% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $84,082,418 | 5,763,017 | 4.58% | 주식 |
| STATE STREET CORP | $78,257,609 | 5,363,784 | 4.26% | 주식 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $73,501,000 | 5,037,787 | 4.00% | 주식 |
| BRAIDWELL LP | $71,756,567 | 4,918,202 | 3.91% | 주식 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $61,886,083 | 4,342,883 | 3.37% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $50,558,727 | 3,465,300 | 2.75% | 콜 옵션 |
| MILLENNIUM MANAGEMENT LLC | $44,930,518 | 3,079,542 | 2.45% | 주식 |
| TORONTO DOMINION BANK | $43,770,000 | 3,000,000 | 2.38% | 콜 옵션 |
| GEODE CAPITAL MANAGEMENT, LLC | $42,933,596 | 2,942,009 | 2.34% | 주식 |
| Driehaus Capital Management LLC | $36,604,049 | 2,508,845 | 1.99% | 주식 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $34,896,129 | 2,391,784 | 1.90% | 주식 |
| AMERICAN CAPITAL MANAGEMENT INC | $32,648,145 | 2,237,707 | 1.78% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $32,593,724 | 2,233,977 | 1.78% | 주식 |
| UBS Group AG | $32,581,659 | 2,233,150 | 1.78% | 콜 옵션 |
| LOOMIS SAYLES & CO L P | $30,838,504 | 2,113,674 | 1.68% | 주식 |
| Aberdeen Group plc | $28,180,950 | 1,931,525 | 1.54% | 주식 |
| D. E. Shaw & Co., Inc. | $27,938,858 | 1,914,932 | 1.52% | 주식 |
| GLENMEDE TRUST CO NA | $20,985,657 | 1,438,359 | 1.14% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $17,689,018 | 1,212,407 | 0.96% | 주식 |
| SEGALL BRYANT & HAMILL, LLC | $15,850,518 | 1,086,396 | 0.86% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $12,685,640 | 869,475 | 0.69% | 주식 |
| AQR CAPITAL MANAGEMENT LLC | $11,918,848 | 816,919 | 0.65% | 주식 |
| SAMLYN CAPITAL, LLC | $11,869,359 | 813,527 | 0.65% | 주식 |
| Connor, Clark & Lunn Investment Management Ltd. | $11,707,337 | 802,422 | 0.64% | 주식 |
| Glenmede Investment Management, LP | $11,359,995 | 1,471,502 | 0.62% | 주식 |
| PRINCIPAL FINANCIAL GROUP INC | $9,141,555 | 626,563 | 0.50% | 주식 |
| HighMark Wealth Management LLC | $8,936,871 | 612,534 | 0.49% | 주식 |
| JUPITER ASSET MANAGEMENT LTD | $7,841,935 | 537,487 | 0.43% | 주식 |
| Public Sector Pension Investment Board | $6,526,545 | 447,330 | 0.36% | 주식 |
| Trexquant Investment LP | $6,358,074 | 435,783 | 0.35% | 주식 |
| GOLDMAN SACHS GROUP INC | $5,559,884 | 381,075 | 0.30% | 주식 |
| Bank of New York Mellon Corp | $5,554,938 | 380,736 | 0.30% | 주식 |
| Granite Investment Partners, LLC | $5,181,507 | 355,141 | 0.28% | 주식 |
| RHUMBLINE ADVISERS | $4,624,054 | 316,935 | 0.25% | 주식 |
| AMERIPRISE FINANCIAL INC | $4,623,822 | 316,917 | 0.25% | 주식 |
| Weiss Asset Management LP | $4,171,558 | 285,919 | 0.23% | 주식 |
| Swiss National Bank | $3,800,695 | 260,500 | 0.21% | 주식 |
| SUSQUEHANNA ADVISORS GROUP, INC. | $3,770,056 | 258,400 | 0.21% | 주식 |
| STATE OF WISCONSIN INVESTMENT BOARD | $3,680,109 | 252,235 | 0.20% | 주식 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3,455,481 | 236,839 | 0.19% | 주식 |
| FMR LLC | $3,409,026 | 233,655 | 0.19% | 주식 |
| Squarepoint Ops LLC | $3,239,505 | 222,036 | 0.18% | 주식 |
| ExodusPoint Capital Management, LP | $3,128,811 | 214,449 | 0.17% | 주식 |
| Legal & General Group Plc | $2,907,700 | 199,294 | 0.16% | 주식 |
| PEAK6 LLC | $2,651,003 | 181,700 | 0.14% | 콜 옵션 |
| FEDERATED HERMES, INC. | $2,510,064 | 172,040 | 0.14% | 주식 |
| BANK OF AMERICA CORP /DE/ | $2,221,357 | 152,252 | 0.12% | 주식 |
| WHITE PINE CAPITAL LLC | $2,167,184 | 148,539 | 0.12% | 주식 |
| PRUDENTIAL FINANCIAL INC | $2,017,870 | 138,305 | 0.11% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $1,987,158 | 136,200 | 0.11% | 주식 |
| BlackRock, Inc. | $1,962,691 | 134,523 | 0.11% | 주식 |
| WELLS FARGO & COMPANY/MN | $1,943,067 | 133,178 | 0.11% | 주식 |
| STEELHEAD PARTNERS LLC | $1,885,028 | 129,200 | 0.10% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $1,787,859 | 122,540 | 0.10% | 주식 |
| Greenhouse Funds LLLP | $1,689,522 | 115,800 | 0.09% | 콜 옵션 |
| PERKINS CAPITAL MANAGEMENT INC | $1,605,483 | 110,040 | 0.09% | 주식 |
| GABELLI FUNDS LLC | $1,597,605 | 109,500 | 0.09% | 주식 |
| ARISTEIA CAPITAL, L.L.C. | $1,571,343 | 107,700 | 0.09% | 주식 |
| IEQ CAPITAL, LLC | $1,524,305 | 104,476 | 0.08% | 주식 |
| Verition Fund Management LLC | $1,477,019 | 101,235 | 0.08% | 주식 |
| GAMCO INVESTORS, INC. ET AL | $1,459,000 | 100,000 | 0.08% | 주식 |
| Fernwood Investment Management, LLC | $1,453,536 | 88,200 | 0.08% | 주식 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1,440,244 | 194,103 | 0.08% | 주식 |
| XTX Topco Ltd | $1,413,552 | 96,885 | 0.08% | 주식 |
| VANGUARD ASSET MANAGEMENT, Ltd | $1,403,354 | 96,186 | 0.08% | 주식 |
| CITADEL ADVISORS LLC | $1,324,772 | 90,800 | 0.07% | 콜 옵션 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,279,178 | 87,675 | 0.07% | 주식 |
| Curi Capital, LLC | $1,256,666 | 86,132 | 0.07% | 주식 |
| MFG WEALTH MANAGEMENT, INC. | $1,217,711 | 83,462 | 0.07% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $1,189,723 | 160,340 | 0.06% | 주식 |
| MetLife Investment Management, LLC | $1,120,293 | 76,785 | 0.06% | 주식 |
| Mariner, LLC | $1,117,405 | 76,587 | 0.06% | 주식 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $1,039,421 | 71,242 | 0.06% | 주식 |
| TWO SIGMA ADVISERS, LP | $983,136 | 83,600 | 0.05% | 주식 |
| Russell Investments Group, Ltd. | $967,068 | 66,283 | 0.05% | 주식 |
| VOYA INVESTMENT MANAGEMENT LLC | $962,429 | 65,965 | 0.05% | 주식 |
| MORGAN STANLEY | $954,638 | 65,431 | 0.05% | 주식 |
| Quantinno Capital Management LP | $945,359 | 64,795 | 0.05% | 주식 |
| Illinois Municipal Retirement Fund | $932,520 | 63,915 | 0.05% | 주식 |
| WINTON GROUP Ltd | $924,700 | 63,379 | 0.05% | 주식 |
| Quantbot Technologies LP | $922,540 | 63,231 | 0.05% | 주식 |
| CHOREO, LLC | $889,115 | 60,940 | 0.05% | 주식 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $884,373 | 60,615 | 0.05% | 주식 |
| MOODY NATIONAL BANK TRUST DIVISION | $860,445 | 58,975 | 0.05% | 주식 |
| Louisiana State Employees Retirement System | $833,089 | 57,100 | 0.05% | 주식 |
| SIMPLEX TRADING, LLC | $796,453 | 54,589 | 0.04% | 주식 |
| JANE STREET GROUP, LLC | $786,401 | 53,900 | 0.04% | 콜 옵션 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $786,109 | 53,880 | 0.04% | 주식 |
| Teton Advisors, LLC | $774,729 | 53,100 | 0.04% | 주식 |
| Invesco Ltd. | $766,515 | 52,537 | 0.04% | 주식 |
| COMMERCE BANK | $764,632 | 52,408 | 0.04% | 주식 |
| Vanguard Global Advisers, LLC | $741,070 | 50,793 | 0.04% | 주식 |
| BARD ASSOCIATES INC | $683,761 | 46,865 | 0.04% | 주식 |
| Alamea Verwaltungs GmbH | $683,702 | 46,861 | 0.04% | 주식 |
| NEW YORK STATE COMMON RETIREMENT FUND | $674,467 | 46,228 | 0.04% | 주식 |
회사 내부자 52 명의 내부자 · 30 임원 · 23 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Anthony P. Zook | Chief Executive Officer | 2025년 6월 1일 M | 20,166 | 0 | 0 | $0 |
| Christopher M Smith | Chief Executive Officer | 2025년 2월 23일 M | 641,585 | 0 | 0 | $0 |
| Mark Mallon | Chief Executive Officer | 2022년 3월 1일 A | 368,051 | 0 | 0 | $0 |
| Jeffrey Scott Sherman | Chief Financial Officer | 2025년 5월 11일 M | 168,332 | 0 | 0 | $0 |
| William Bonello | Chief Financial Officer | 2022년 4월 28일 M | 191,548 | 0 | 0 | $0 |
| Sharon Virag | Chief Financial Officer | 2019년 3월 1일 A | 10,944 | 0 | 0 | $0 |
| Vishal Sikri | President Advanced Diagnostics | 2024년 2월 23일 A | 148,455 | 0 | 0 | $0 |
| David Sholehvar | President, Clinical Services | 2022년 8월 1일 A | 43,216 | 0 | 0 | $0 |
| George Cardoza | President & COO, Lab Ops | 2022년 3월 2일 F | 244,157 | 0 | 0 | $0 |
| Gina M Wallar | President, Pharma Services | 2022년 3월 1일 A | 33,443 | 0 | 0 | $0 |
| Clive Morris | President of Inivata | 2021년 12월 30일 A | 41,280 | 0 | 0 | $0 |
| Robert J. Shovlin | President, Clinical Services | 2021년 5월 25일 M | 150,101 | 0 | 0 | $0 |
| Warren Stone | Pres & Chief Operating Officer | 2025년 5월 11일 M | 108,280 | 0 | 0 | $0 |
| Alicia C Olivo | EVP, GC & Business Development | 2025년 9월 1일 F | 47,940 | 0 | 0 | $0 |
| Melody Harris | Chf Ops Off, Pres, Informatics | 2025년 2월 23일 M | 109,755 | 0 | 0 | $0 |
| Shashikant Kulkarni | Chief Scientific Officer | 2023년 4월 1일 F | 82,673 | 0 | 0 | $0 |
| Cynthia J Dieter | Chief Accounting Officer | 2023년 3월 2일 F | 29,765 | 0 | 0 | $0 |
| Douglas Matthew Brown | Chief Strategy Officer | 2022년 4월 1일 A | 158,684 | 0 | 0 | $0 |
| Halley E Gilbert | Chief Legal Officer | 2022년 3월 1일 A | 147,396 | 0 | 0 | $0 |
| Kathryn B Mckenzie | Chief Sustainability/Risk Ofcr | 2022년 1월 11일 M | 49,361 | 0 | 0 | $0 |
| Jennifer Balliet | VP and Chief Culture Officer | 2021년 12월 30일 A | 48,615 | 0 | 0 | $0 |
| Lawrence Martin Weiss | Chief Medical Officer | 2021년 4월 22일 M | 130,847 | 0 | 0 | $0 |
| Denise E Pedulla | General Counsel | 2021년 3월 2일 A | 60,643 | 0 | 0 | $0 |
| Steven G. Brodie | VP - Pharma Operations | 2018년 10월 22일 M | 45,953 | 0 | 0 | $0 |
| Steven A Ross | CIO | 2018년 5월 10일 X | 4,500 | 0 | 0 | $0 |
| Maher Albitar | Chief Medical Officer | 2017년 5월 25일 A | 60,692 | 0 | 0 | $0 |
| Mark Alan Machulcz | Vice President of Operations | 2016년 1월 28일 A | — | 0 | 0 | $0 |
| Robert H. Horel | Vice President GM PathLogic | 2015년 12월 29일 X | 51,218 | 0 | 0 | $0 |
| Robert P Gasparini | Chief Science Officer | 2014년 5월 22일 X | 8,439 | 0 | 0 | $0 |
| Mark W Smits | Chief Commercial Officer | 2011년 5월 18일 M | 0 | 0 | 0 | $0 |
| Carolyn S Starrett | 이사 | 2026년 6월 23일 A | — | 0 | 0 | $0 |
| Lynn A. Tetrault | 이사 | 2026년 6월 15일 S | 86,115 | 0 | 2 | $-118,824 |
| Marjorie C Green | 이사 | 2026년 6월 1일 A | 22,964 | 0 | 0 | $0 |
| Neil Gunn | 이사 | 2026년 6월 1일 A | 51,177 | 0 | 0 | $0 |
| Michael Aaron Kelly | 이사 | 2026년 6월 1일 A | 67,086 | 0 | 0 | $0 |
| David Brian Perez | 이사 | 2026년 6월 1일 A | 56,967 | 0 | 0 | $0 |
| John P. Kenny | 이사 | 2026년 6월 1일 A | 5,893 | 0 | 0 | $0 |
| Stephen M Kanovsky | 이사 | 2026년 6월 1일 A | 75,421 | 0 | 0 | $0 |
| Felicia Williams | 이사 | 2026년 6월 1일 A | 30,237 | 0 | 0 | $0 |
| Elizabeth Floegel | 이사 | 2025년 6월 1일 A | 23,590 | 0 | 0 | $0 |
| Alison L. Hannah | 이사 | 2025년 6월 1일 M | 131,023 | 0 | 0 | $0 |
| Bruce K Crowther | 이사 | 2023년 8월 10일 A | 65,120 | 0 | 0 | $0 |
| Rachel A Stahler | 이사 | 2022년 6월 10일 A | 21,335 | 0 | 0 | $0 |
| David Daly | 이사 | 2022년 6월 10일 A | 17,179 | 0 | 0 | $0 |
| Kevin C Johnson | 이사 | 2021년 12월 22일 M | 37,398 | 0 | 0 | $0 |
| Douglas M Van Oort | 이사 | 2021년 8월 1일 F | 2,468,797 | 0 | 0 | $0 |
| Steven C Jones | 이사 | 2021년 1월 7일 M | 90,218 | 0 | 0 | $0 |
| Raymond R Hipp | 이사 | 2020년 11월 16일 S | 66,800 | 0 | 0 | $0 |
| William J Robison | 이사 | 2017년 5월 25일 A | 183,348 | 0 | 0 | $0 |
| Michael T Dent | 이사 | 2014년 12월 4일 S | 1,384,150 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 1 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| IRS IDENTIFICATION NO. NeoGenomics, Inc. | 2007년 4월 12일 | — | 최초 제출 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 62 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 1.12% | 167,212 SH | 2026년 8월 8일 | 일간 |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1.09% | 113,008 SH | 2026년 8월 8일 | 일간 |
| LFSC · RBB Fund, Inc. | 0.43% | 43,071 NS | 2026년 5월 31일 | N-PORT |
| IHF · iShares Trust | 0.31% | 243,554 SH | 2026년 8월 8일 | 일간 |
| FYC · First Trust Exchange-Traded AlphaDE… | 0.14% | 154,408 NS | 2026년 4월 30일 | N-PORT |
| IJT · iShares Trust | 0.13% | 700,692 SH | 2026년 8월 8일 | 일간 |
| XJR · iShares Trust | 0.13% | 15,435 SH | 2026년 8월 8일 | 일간 |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0.12% | 19,262 SH | 2026년 8월 8일 | 일간 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.12% | 211,878 SH | 2026년 8월 8일 | 일간 |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.12% | 89,895 SH | 2026년 8월 8일 | 일간 |
| IWN · iShares Trust | 0.12% | 1,117,630 SH | 2026년 8월 8일 | 일간 |
| IJR · iShares Trust | 0.11% | 7,947,524 SH | 2026년 8월 8일 | 일간 |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.11% | 104,297 SH | 2026년 8월 8일 | 일간 |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.10% | 455,144 SH | 2026년 8월 8일 | 일간 |
| NUSC · Nushares ETF Trust | 0.10% | 135,666 NS | 2026년 4월 30일 | N-PORT |
| IJS · iShares Trust | 0.09% | 489,210 SH | 2026년 8월 8일 | 일간 |
| VIOV · VANGUARD ADMIRAL FUNDS | 0.09% | 116,046 SH | 2026년 8월 8일 | 일간 |
| ESML · iShares Trust | 0.09% | 158,897 SH | 2026년 8월 8일 | 일간 |
| FYX · First Trust Exchange-Traded AlphaDE… | 0.07% | 93,313 NS | 2026년 4월 30일 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0.07% | 13,856 NS | 2026년 5월 31일 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0.07% | 85,056 SH | 2026년 8월 8일 | 일간 |
| IWM · iShares Trust | 0.06% | 3,340,583 SH | 2026년 8월 8일 | 일간 |
| ISCG · iShares Trust | 0.06% | 40,428 SH | 2026년 8월 8일 | 일간 |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.06% | 49,165 NS | 2026년 4월 30일 | N-PORT |
| SAA · ProShares Trust | 0.06% | 1,546 NS | 2026년 5월 31일 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.06% | 757,699 SH | 2026년 8월 8일 | 일간 |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0.05% | 33,295 NS | 2026년 4월 30일 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.05% | 1,728,845 SH | 2026년 8월 8일 | 일간 |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.04% | 106,278 NS | 2026년 5월 31일 | N-PORT |
| RSSL · Global X Funds | 0.04% | 55,874 NS | 2026년 4월 30일 | N-PORT |
| ITWO · ProShares Trust | 0.03% | 6,071 NS | 2026년 5월 31일 | N-PORT |
| ISCB · iShares Trust | 0.03% | 5,811 SH | 2026년 8월 8일 | 일간 |
| VHT · VANGUARD WORLD FUND | 0.03% | 388,986 SH | 2026년 8월 8일 | 일간 |
| SCHA · SCHWAB STRATEGIC TRUST | 0.03% | 628,556 NS | 2026년 5월 31일 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.03% | 425,333 NS | 2026년 4월 30일 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.03% | 14,399 NS | 2026년 4월 30일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.02% | 1,492,431 SH | 2026년 8월 8일 | 일간 |
| VB · VANGUARD INDEX FUNDS | 0.02% | 2,990,594 SH | 2026년 8월 8일 | 일간 |
| UWM · ProShares Trust | 0.02% | 4,748 NS | 2026년 5월 31일 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.02% | 60,531 NS | 2026년 4월 30일 | N-PORT |
| WSML · iShares Trust | 0.02% | 7,690 SH | 2026년 8월 8일 | 일간 |
| SMLF · iShares Trust | 0.02% | 45,201 SH | 2026년 8월 8일 | 일간 |
| URTY · ProShares Trust | 0.01% | 4,804 NS | 2026년 5월 31일 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.01% | 5,288 NS | 2026년 4월 30일 | N-PORT |
| IWO · iShares Trust | 0.01% | 113,167 SH | 2026년 8월 8일 | 일간 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 12,627 SH | 2026년 8월 8일 | 일간 |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.01% | 5,219 NS | 2026년 5월 31일 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.01% | 339,840 NS | 2026년 4월 30일 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.01% | 15,340 NS | 2026년 4월 30일 | N-PORT |
| HDG · ProShares Trust | 0.01% | 121 NS | 2026년 5월 31일 | N-PORT |